Impact Of Low Infliximab Dose Regimen On Treatment Response and Drug Survival In 462 Patients With Psoriatic Arthritis: Results From The Nationwide Registries Danbio and Icebio

Bente Glintborg, Bjorn Gudbjornsson, Niels Steen Krogh, Emina Omerovic, Natalia Manilo, Mette Holland-Fischer, Hanne M. Lindegaard, Anne Gitte Loft, Henrik Nordin, Laura Johnsen, Sussi Flejsborg Oeftiger, Annette Hansen, Claus Rasmussen, Gerdur Grondal, Arni Jon Geirsson, Merete Lund Hetland

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
Artikelnummer314
TidsskriftArthritis & Rheumatism
Vol/bind65
Udgave nummer10 (Supplement)
Sider (fra-til)S133
ISSN0004-3591
StatusUdgivet - 2013
BegivenhedAnnual Meeting of American College of Rheumatology, ACR, and Association of Rheumatology Health Professionals, ARHP - San Diego, CA, USA
Varighed: 25 okt. 201330 okt. 2013
Konferencens nummer: 77, 48

Konference

KonferenceAnnual Meeting of American College of Rheumatology, ACR, and Association of Rheumatology Health Professionals, ARHP
Nummer77, 48
LandUSA
BySan Diego, CA
Periode25/10/201330/10/2013

Citationsformater

Glintborg, B., Gudbjornsson, B., Krogh, N. S., Omerovic, E., Manilo, N., Holland-Fischer, M., Lindegaard, H. M., Loft, A. G., Nordin, H., Johnsen, L., Oeftiger, S. F., Hansen, A., Rasmussen, C., Grondal, G., Geirsson, A. J., & Hetland, M. L. (2013). Impact Of Low Infliximab Dose Regimen On Treatment Response and Drug Survival In 462 Patients With Psoriatic Arthritis: Results From The Nationwide Registries Danbio and Icebio. Arthritis & Rheumatism, 65(10 (Supplement)), S133. [314]. https://ww2.rheumatology.org/apps/Areas/MyAnnualMeeting/Content/images/2013ACR_ARHPAnnualMeetingAbstractSupplement.pdf